During the past decade, The Cardiac Center at Creighton University conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Cardiac Center at Creighton University" #1 sponsor was "Creighton University" with 8 trials, followed by "Boston Scientific Corporation" with 2 trials sponsored, "Abbott" with 1 trials sponsored, "AtheroGenics" with 1 trials sponsored and "Biosense Webster, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Cardiac Center at Creighton University" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator, "Northwestern University" with 1 trials as a collaborator and "Orion Corporation, Orion Pharma" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "The Cardiac Center at Creighton University" are "Coronary Artery Disease" (4 trials), "Cardiovascular Disease" (3 trials), "Heart Failure, Congestive" (2 trials), "Myocardial Infarction" (2 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "The Cardiac Center at Creighton University" in a lesser frequency.

Most popular intervention types in "The Cardiac Center at Creighton University" are "Drug" (9 trials), "Device" (3 trials), "Dietary Supplement" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "AGI-1067" (1 trials), "Allen's test" (1 trials), "Aspirin" (1 trials) and "Bendavia (MTP-131)" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Cardiac Center at Creighton University" are 15 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "The Cardiac Center at Creighton University". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in The Cardiac Center at Creighton University, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in The Cardiac Center at Creighton University, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 4 trials that are defined as “Not Applicable".